Monographs & Whitepapers
Immune Globulins: Therapeutic, Pharmaceutical, Cost, and Administration Considerations
With so many immune globulin products on the market, providers frequently have questions about the best approach to product selection. The charts in this updated review provide relevant information to help clinicians guide those decisions.
JUNE 26, 2025
RFID Technology in Children's Hospitals
The use of radio-frequency identification (RFID) has gained momentum in the health care industry, particularly in the pharmacy, as an effective way to record and track medications throughout a system. In this article, 3 pharmacy experts discuss the safety, workflow, and cost advantages of RFID in the management of medications for a vulnerable population.
MAY 1, 2025
A Targeted Treatment for Carbapenem-Resistant Acinetobacter baumannii
The approval of sulbactam-durlobactam for the treatment of carbapenem-resistant Acinetobacter baumannii infections under the FDA fast-track process sets an important precedent for the development of critical antimicrobials for our most resistant organisms. In this monograph, 2 infectious disease specialists review the clinical trial data and early case reports of this important agent, as well as the updated guidance from the Infectious Diseases Society of America.
APRIL 1, 2025
Antimicrobial Efficacy
This pocket folder is intended to be a reference to describe the potential in vivo activity of various antimicrobial agents when the identity of the infecting organism is known.
MARCH 24, 2025
Optimizing Care for Patients Requiring Parenteral Nutrition: Spotlight on Pediatrics
Strategies for improved parenteral nutrition administration have advanced significantly in the past few decades, and the FDA has approved new products with pediatric indications. In this Special Report, Debora Duro, MD, MS, reviews the available options as well as the published guidelines to assist clinicians in the safe and efficacious use of parenteral nutrition in pediatric patients.
MARCH 20, 2025
Decreasing Postoperative Adverse Events and Waste Costs With Low-Dose Opioid And Ready-to-Administer (RTA) Medications
This Special Report reviews data evaluating the association of adverse outcomes and intraoperative opioid dose; describes data quantifying the amount and cost of drug waste based on multiple ready-to-administer (RTA) and vial sizes, highlighting the need for product size optimization; outlines the effect of drug waste on the health care system, patient, and environment; quantifies the holistic costs associated with drug waste; and proposes best practice recommendations to optimize product size to improve patient outcomes and reduce excess costs.
FEBRUARY 11, 2025
RFID Systems: Pharmacy Technicians Leading the Way
The implementation of radio frequency identification (RFID) in pharmacy for the real-time tracking, storage, and analysis of tagged medications is picking up speed. This article highlights the critical role of pharmacy technicians in the management of RFID systems, freeing pharmacists from operational concerns to focus on high-priority patient care tasks.
OCTOBER 18, 2024
The NOPAIN Act: Clinical and Financial Opportunities in Hospital Outpatient and Ambulatory Settings
This monograph features the clinical perspectives from those working in the trenches of postsurgical pain management, and addresses how their institutions are preparing for new separate Medicare reimbursement for certain branded non-opioid analgesics for procedures in the hospital outpatient and ambulatory settings.
OCTOBER 14, 2024
Emerging Data for Parenteral Nutrition Optimization in the ICU
During the 2024 Critical Care Congress of the Society of Critical Care Medicine, David C. Evans, MD, FACS, FCCM, FASPEN, and Sara V. Cogle, PharmD, BCCCP, BCNSP, partnered to discuss lipid emulsions with clinician attendees. They reviewed current US lipid options; safety, compatibility, and stability information; clinical practice guidelines; lipid summit consensus statements; and the latest scientific studies. This Special Report reviews these important topics and how the emerging data may influence current clinical practice.
OCTOBER 3, 2024
Gohibic™ (vilobelimab): A Treatment Option For Critically Ill COVID-19 Patients
This article describes the standard of care for hospitalized patients with COVID-19 in need of supplemental oxygen and the use of vilobelimab as part of a treatment regimen, supported by clinical data for patients who meet the Emergency Use Authorization criteria.
SEPTEMBER 23, 2024
Use of Dalbavancin in Optimizing the Management of ABSSSIs in Patients With Obesity or Diabetes
This Special Report reviews data on the use of dalbavancin for the treatment of ABSSSIs to support safety and efficacy in high-risk populations, including obese and diabetic patients.
JULY 9, 2024
Achieving Operational Excellence With Pre-Tagged RFID Products
The use of radio frequency identification (RFID) is gaining momentum as an effective, real-time method for tracking medications in health systems. In addition, pre-tagged RFID products reduce the need for manual tagging, tag placement, and associating drug information. This article highlights the experience of pharmacy experts in the implementation and use of this important technology at their institutions.
JULY 3, 2024
